Raphael Pharma corrects CTO deal: $9k/month, 999k warrants at $0.01, royalty share

Raphael Pharmaceutical Inc.

Service agreement with CTO Dr. Igal Louria Hayon corrected, monthly fee $9,000 through Dec 31, 2022.
Issuance of 999,000 warrants at $0.01 per share, expiring July 5, 2024.
Additional 350,000 warrants at $0.01 if company initiates cannabis clinical trial or new cannabis research.
Royalty payments: 15% of net royalties from medical cannabis CBD oil for COVID-19 and for rheumatoid arthritis.
Term through Dec 31, 2023; termination requires 120 days notice and fee equal to remaining monthly fees.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.